| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10469612 | Journal of Psychosomatic Research | 2011 | 8 Pages |
Abstract
SS was not directly associated with efficacy measures, such as SVR. However, baseline SS predicted an increase in symptomatology over the course of antiviral therapy. Baseline depression was also significantly associated with symptom-reporting.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Donna M. Evon, Denise A. Esserman, Darmendra Ramcharran, Jason E. Bonner, Michael W. Fried,